C. Meg McLachlin

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 623 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation.

Bradley J. Quade, C. Meg McLachlin, V Soto-Wright et al. · PubMed · 1997 · 97 citations

Medicine, Oncology, Pathology +16

H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas

James A. Anderson, Jonathan C. Irish, C. Meg McLachlin et al. · Archives of Otolaryngology - Head and Neck Surgery · 1994 · 87 citations

Medicine, Oncology, Oral Pathology +17

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)

Helen Mackay, Steven Gallinger, Ming‐Sound Tsao et al. · European Journal of Cancer · 2010 · 84 citations

Medicine, Cancer Biology, Oncology +13

Pathobiology of vulvar squamous neoplasia

Christopher P. Crum, C. Meg McLachlin, James E. Tate et al. · Current Opinion in Obstetrics & Gynecology · 1997 · 83 citations

Medicine, Oncology, Pathology +15